Challenges with public anti-cancer drug-reimbursement in Ireland: 1. It takes currently on average ~2 years from EU Medicines Agency approval to HSE Ireland (public) reimbursement. 2. Irish insurance companies have promised immediate reimbursement directly following EU Medicines Agency approval for

We’re enormously proud of our radiation oncology trainees and today we say farewell to two stellar colleagues as they head off on their fellowships; Mary Burke to Manchester and Karen Olden to Melbourne ⁦Mary Burke⁩ ⁦The Christie NHS⁩ ⁦Peter Mac Radiation Oncology⁩

Charles Gillham MD RadiationTherapyTCD Gerry Hanna NCCP Ruth Guhan Rangaswamy Prof Sinead Brennan #proton #childhoodcancer

Incredible results…which will hopefully lead to sustained responses

A new Parliament sits today If they want to think about a Cancer Plan - here's a starter for 10 The Lancet Oncology Pressure points explored and recommendations offered thelancet.com/journals/lanon…

A very fond farewell to the legendary Agnes Hayes after 33 years in St Luke’s, Rathgar; educator, trainer and leader - an inspirational nurse and always smiling. ⁦Dublin Midlands Hospital Group⁩ ⁦

Such an important survey. Please share widely Sarcoma Cancer Ireland

Ireland AM - Raising awareness about symptoms of sarcoma, its rarity and importance of an early diagnosis. Warning signs: A growing lump (often painless) More than size of a golf ball Deep to skin Especially in arm, leg, back, flank… Know your body… virginmediatelevision.ie/player/show/80…

It’s estimated that around 300,000 people in Ireland are living with a rare disease. The new National Rare Disease Strategy will set out the vision for rare disease services in Ireland. To make a submission, visit gov.ie/RareDiseaseCon…

Oncologist: People with cancer are waiting too long for treatment in Ireland (via TheJournal.ie) jrnl.ie/6432861

Thank you michaeltmccarthy for highlighting a situation that is mirrored in multiple hospitals across the country. It is apparent that the moratorium has in fact not ended but has been re-phrased. We have 103 vacant posts. We will be penalised if we fill more than 10 #SLRON HSE Ireland

When lots of Healthcare professionals are on HSE panels since October, waiting to commence positions. HSE Ireland Bernard Gloster Stephen Donnelly

Come and work in Dublin - at one of Europes largest radiation oncology departments: 2 exciting locum consultant radiation oncology posts. ⁦⁦ESTRO⁩ ⁦ASTRO⁩ ⁦NCCP⁩ ⁦HSE Ireland⁩ ⁦Dublin Midlands Hospital Group⁩ ⁦RCSI⁩ hse.ie/eng/staff/jobs…

Massive congratulations to Jenny Rogers - the next Deputy Patient Services Manager in the St Luke’s Radiation Oncology Network. This post could not have been gone to a more dynamic and driven person. We are delighted! jen Jenny Rogers Dublin Midlands Hospital Group

Recently, I was asked by NewstalkFM to comment on this article: irishtimes.com/health/2024/07… I am surprised that it is only a 30% reduction. In medical oncology in Ireland, in general, there has never been a ‘waiting list’ to access a consultant opinion, public or private. Since

Two really fantastic promotions to CNM3 in the St Luke’s Radiation Oncology Network admin team. Noreen Mulligan as education lead and Noeleen McDaid as patient flow coordinator ⁦Dublin Midlands Hospital Group⁩ ⁦HSE Ireland⁩ #SLRON

Sarcoma cancer with Dr Mark Doherty and Prof Charles Gillham - The Answers for Cancers | Podcast on Spotify put together by two fantastic nurses ⁦Sarcoma Cancer Ireland⁩ ⁦Irish Cancer Society⁩ ⁦St Vincent's University Hospital (SVUH)⁩ open.spotify.com/episode/1nVRRp…

This is very welcome news. However there is a ~30% nationwide shortage of radiation therapists. Ireland is struggling to deliver timely radiotherapy. It is imperative that college places for these HSCPs are also expanded. HSE Ireland RadiationTherapyTCD Iirrt Patrick O'Donovan

A truly fantastic multidisciplinary trial of enormous benefit to patients requiring radiotherapy to the head and neck

Huge progress 👏 Insertion of the first rectal spacer in St Luke’s Radiation Oncology Network, Dublin; helping to minimise the risk of rectal toxicity from prostate radiotherapy Boston Scientific NCCP Dublin Midlands Hospital Group HSE Ireland